The Use of Direct-to-Patient Methods in Decentralized Clinical Trials in Israel
Direct-to-Patient
Clinical trials are essential for advancing medical science and developing new treatments. However, patient recruitment and retention have long been significant challenges in the clinical research process. Direct-to-patient (DtP) approaches seek to address these issues by engaging patients directly in clinical trials, outside the traditional healthcare system. In Israel, a country known for its thriving healthcare and life sciences sector, the adoption of DtP strategies in clinical trials is of particular interest.
Related Education Resources.
All ResourcesThe Exponential Growth of Decentralized Trials, Direct-to-Patient and the Future of the Clinical Trials Landscape in Europe
Topics: Conference, Regulatory
Executive Summary
Members
PATIENT Receptivity to Direct-to-Patient Shipment in Clinical Trials - a GCSG sponsored study
Topic: Direct-to-Patient
White Paper
Members
Pelican webinar - Impact of COVID-19 on Cold Chain
Topics: Cold Chain, Supply Chain
Webinar
Free
